C16orf89 | Chromosome 16 open reading frame 89 | Predicted secreted proteins
| | | | | Group enriched |
CAPN13 | Calpain 13 | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
DCC | DCC netrin 1 receptor | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
GPIHBP1 | Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 | Disease related genes Predicted secreted proteins
| | | | | Group enriched |
LAMP3 | Lysosomal-associated membrane protein 3 | CD markers Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
PLA2G3 | Phospholipase A2, group III | Enzymes Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
SDR16C5 | Short chain dehydrogenase/reductase family 16C, member 5 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
SLC22A31 | Solute carrier family 22, member 31 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
TBX5 | T-box 5 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
XXbac-BPG116M5.17 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000410815}; cDNA FLJ55673, highly similar to Complement factor B {ECO:0000313|EMBL:BAG64956.1} | Predicted secreted proteins
| | | | | Group enriched |
AK1 | Adenylate kinase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
CSF2 | Colony stimulating factor 2 (granulocyte-macrophage) | Cancer-related genes Predicted secreted proteins
| | | | | Group enriched |
DCSTAMP | Dendrocyte expressed seven transmembrane protein | Predicted membrane proteins
| | | | | Tissue enriched |
DTHD1 | Death domain containing 1 | Predicted intracellular proteins
| | | | | Group enriched |
FFAR4 | Free fatty acid receptor 4 | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
LGI3 | Leucine-rich repeat LGI family, member 3 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
MROH9 | Maestro heat-like repeat family member 9 | Predicted intracellular proteins
| | | | | Group enriched |
SCGB3A1 | Secretoglobin, family 3A, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SCTR | Secretin receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Group enriched |
TBX4 | T-box 4 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
TSPAN32 | Tetraspanin 32 | Predicted membrane proteins
| | | | | Group enriched |
WIF1 | WNT inhibitory factor 1 | Cancer-related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
ABCA3 | ATP-binding cassette, sub-family A (ABC1), member 3 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ADAMTS8 | ADAM metallopeptidase with thrombospondin type 1 motif, 8 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AGBL1 | ATP/GTP binding protein-like 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
AGRP | Agouti related neuropeptide | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ALOX15 | Arachidonate 15-lipoxygenase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
ALPL | Alkaline phosphatase, liver/bone/kidney | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ANKRD29 | Ankyrin repeat domain 29 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ATP13A4 | ATPase type 13A4 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
BPIFA1 | BPI fold containing family A, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C1orf110 | Chromosome 1 open reading frame 110 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C1orf116 | Chromosome 1 open reading frame 116 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C2orf91 | Chromosome 2 open reading frame 91 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C5orf38 | Chromosome 5 open reading frame 38 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C6orf223 | Chromosome 6 open reading frame 223 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CALCRL | Calcitonin receptor-like | G-protein coupled receptors Plasma proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
CASS4 | Cas scaffolding protein family member 4 | Cytoskeleton related proteins Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CAV2 | Caveolin 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CCL18 | Chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLEC14A | C-type lectin domain family 14, member A | Predicted membrane proteins
| | | | | Tissue enhanced |
CLIC5 | Chloride intracellular channel 5 | Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
COL4A3 | Collagen, type IV, alpha 3 (Goodpasture antigen) | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COL6A5 | Collagen, type VI, alpha 5 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COL6A6 | Collagen, type VI, alpha 6 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CPAMD8 | C3 and PZP-like, alpha-2-macroglobulin domain containing 8 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CRTAC1 | Cartilage acidic protein 1 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CTD-2132N18.3 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000468275} | Predicted intracellular proteins
| | | | | Tissue enhanced |